| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/27/2002 | DE10062766A1 Arzneimittel für die Behandlung oder Prävention einer Chemotherapie-induzierten Mukositis und anderer Chemotherapie-Nebenwirkungen Drugs for the treatment or prevention of chemotherapy-induced mucositis, and other side effects of chemotherapy |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2436531A1 Isolation of purified tgf-.beta.1 and tgf-.beta.2 from bone tissue techsource patent |
| 06/27/2002 | CA2433436A1 Gene expression profiles associated with osteoblast differentiation |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432992A1 Fab i and inhibition of apicomplexan parasites |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
| 06/27/2002 | CA2432797A1 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | CA2432767A1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | CA2432531A1 Use of dna repair enzymes as mmp-1 inhibitors |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432257A1 Treatment of bone disorders by modulation of fgfr3 |
| 06/27/2002 | CA2432157A1 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2432031A1 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431986A1 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430782A1 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | CA2429519A1 Novel human secreted proteins and polynucleotides encoding the same |
| 06/26/2002 | EP1217070A1 Selective cytotoxic fusion proteins |
| 06/26/2002 | EP1217068A2 Oil palm (genus Elaeis) peroxiredoxin gene and uses thereof |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1217066A1 Modulation of ATP-binding cassette transporter activity |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1216714A1 Cellular and serum protein anchors and conjugates |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216709A1 Use of activated coagulation factor VII for treating thrombolytic therapy-induced major bleedings |
| 06/26/2002 | EP1216708A1 A disinfectant for teats of animals, and a method for improving microorganism-environment harmful for animals |
| 06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
| 06/26/2002 | EP1216702A2 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 06/26/2002 | EP1216685A2 Personal care compositions |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216296A1 Bioengineered collagen fibrils |
| 06/26/2002 | EP1216258A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 06/26/2002 | EP1216055A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 06/26/2002 | EP1216052A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 06/26/2002 | EP1216051A1 Anti cancer agent and method of treatment of cancer |
| 06/26/2002 | EP1216049A2 Methods for treating muscular dystrophy with bone marrow cells |
| 06/26/2002 | EP1216040A1 Agents for reducing cholesterol-uptake and lipid-uptake |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP1143998A4 Treatment of hypertension |
| 06/26/2002 | EP1073414B1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 06/26/2002 | EP1007072A4 Glial cell line-derived neurotrophic factor receptors |
| 06/26/2002 | EP0906120B1 Compositions comprising a combination of bone morphogenetic protein and parathyroid hormone-related peptide |
| 06/26/2002 | EP0904094A4 Treatment of bone disorders with adrenomedullin |
| 06/26/2002 | EP0830137A4 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 06/26/2002 | EP0754050B1 Anti gram positive bacterial methods and materials |
| 06/26/2002 | EP0693933B1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 06/26/2002 | EP0692963B1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0580790B1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355842A Methods for making proteins containing free cysteine residues |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355812A Pseudomycin analogs |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355794A Cyclo-imino depsipeptides and their utilization in controlling endoparasites |
| 06/26/2002 | CN1355714A LIM Mineralization protein splice variants |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355711A Method for inhibiting brain tumor growth |
| 06/26/2002 | CN1355708A HCV combination therapy containing ribavirin in association with antioxidants |
| 06/26/2002 | CN1355707A Use of interleukin-11 to treat hemorrhagic shock |
| 06/26/2002 | CN1355706A 因子 Factor |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355316A Polypeptide-dimethylallyl diphosphate insomerase 11.99 and polynucleotide for coding it |
| 06/26/2002 | CN1355315A Polypeptide-human dihydroorotase 14.08 and polynucleotide for coding it |
| 06/26/2002 | CN1355314A Polypeptide-human adenosine triphosphate dependent Ser protein hydrolase 11.66 and polynucleotide for coding it |
| 06/26/2002 | CN1355313A Polypeptide-human endoprotease 9.35 and polynucleotide for coding it |
| 06/26/2002 | CN1355312A Polypeptide-signal peptidase 9.79 and polynucleotide for coding it |
| 06/26/2002 | CN1355311A Polypeptide-human protein Ser-Thr phosphatase 14.30 and polynucleotide for coding it |
| 06/26/2002 | CN1355310A Polypeptide-human protein phosphatase 2A alpha subunit 22.66 and polynucleotide for coding it |
| 06/26/2002 | CN1355309A Polypeptide-human protein phosphatase 1 regulatory factor subunit 10-9.79 and polynucleotide for coding it |
| 06/26/2002 | CN1355308A Polypeptide-human RNA uncoiling enzyme 12.54 and polynucleotide for coding it |
| 06/26/2002 | CN1355307A Polypeptide-human uridylic acid kinase 9.57 and polynucleotide for coding it |
| 06/26/2002 | CN1355306A Polypeptide-human protein kinase Nek2-11.11 and polynucleotide for coding it |
| 06/26/2002 | CN1355305A Polypeptide-Ser/Thr protein kinase 9.79 and polynucleotide for coding it |
| 06/26/2002 | CN1355304A Polypeptide-human VD hydroxylase 11.88 and polynucleotide for coding it |
| 06/26/2002 | CN1355303A Polypeptide-human lysyloxidase 54.45 and polynucleotide for coding it |
| 06/26/2002 | CN1355302A Polypeptide-short-chain dehydrogenase/reductase 10.89 and polynucleotide for coding it |
| 06/26/2002 | CN1355301A Polypeptide-human pterin Mo oxido-reductase 14.63 and polynucleotide for coding it |
| 06/26/2002 | CN1355300A Polypeptide-human tyrosinase 46.64 and polynucleotide for coding it |
| 06/26/2002 | CN1355299A Polypeptide-human uracil diphosphate glycopyrophosphorylase 100.47 and polynucleotide for coding it |
| 06/26/2002 | CN1355298A Polypeptide-40KDa subunit 9.35 of RNA polymerase I and polynucleotide for coding it |